No content available.
18F-flotufolastat PET/CT shows high inter- and intrareader agreement rates
Subcutaneous nivolumab under review in EU for solid tumors
FDA approves durvalumab/chemo for muscle–invasive bladder cancer
FDA approves expanded label for 177Lu-PSMA-617 in mCRPC
